Member Info for Strictlyslick

Really want to get in in the mid 6p's....a risky game bearing in mind how fast we can rise...

It doenst look like ACTA is going to drop back to 8p for my buy back in at a profit (having sold at 9.63)...I may even have to buy back in and take a hit at this rate....damn you ACTA for being a good company. I for one am looking forward to the end of the month when the next set of 6mnth results are due - should show slowly increasing revenue....and Septembers results should show a spike in revenue as things start to take off properly :-)

Orosur Mining states that their intent is to provide 1/3 of free cash flow as a dividend. So, on a base calculation of 2014 average gold price of $1,500, cash costs of $810 and fixed admin and overheads equating to $190 per ounce (allowing for $13m per annum overheads which is quite high actually), there would be $500 free cashflow. so, $167 per ounce would be the dividend. 167 X 70000 (target production) = £7,490,000 (after conversion of 1.56:1). This equates to 9.4p per share...24.7% yield if you took the risk of buying and holding till 2014. Have I got that right?

Since no one else is posting - http://www.investegate.co.uk/Article.aspx?id=201209040700074085L

look how quiet it is over here...such excitement only a few months ago and now....dead.

Its a simple blib I'm afraid guys - nothing out of the ordinary. Same thing happened on Lloyds during the 08 crash - went from 65p to 245p on google finance. This is a sit back and wait share I'm afraid - you will see my last two posts which (if I do say so myself) makes interesting points. Therakind looks like it could be, on recent of royalties over the next few years, be floated to fund expansion, the value of which would be underlined by a revenue stream. Ipsol Energy likewise should be shown to make good progress this year, which may be reflected in an increase in fair valuation of assets on IPS' books. Half management report is duie in around a month, so we shall see then what progress has been made.

My average here is over 3p! Sounds scary but its only 10,000 shares from when I first started investing - I'll add a few hundred thousand when the timings right - just need one of my others stocks to improve a little first :-)

This was taken from the Viropharma's full year accounts to 31st December 2011....'charges to reflect the increase in the fair value of the contingent consideration related to the acquisition of Buccolam of $4.6 million'. It suggests that the total milestone payments made in consideration of Buccolam from Therakind was $4.6m. IPSO owns 36% of Therakind....$1.65m increase in value (of course its not all converted to profit but its an illustration). Therekind will be getting paid royalties for the sale of Buccolam, but we are not privy to the level of the royalty in terms of % or price...hopefully the next set of accounts will shed light on this. I feel that the next set of accounts will show a hefty uplift in NAV as a result of the Therakind stake.

Approval for use in Wales NHS, reported 20th June http://www.nelm.nhs.uk/en/NeLM-Area/Evidence/Drug-Specific-Reviews/AWMSG-issues-Final-Appraisal-Recommendation-on-midazolam-Buccolam-for-seizures-in-infants-children-and-adolescents/ IPSO has a 36% share in Therekind which will receive royalties on sales of Buccolam by Viropharma.

I thinbk you're going to have to wait till the half yearly reports for an update mate.

when I should buy a few more shares in this company. have a very megre 10,000 shares at 3p (laughable I know). But with the JV due to be underway in the next 3 months or so (based on timeframe in RNS and assuming it hasn't slipped) and revenues due to be generated in H113 from the JV, at this price (and noting the very little dilution that tends to take place) I think I may have to shortly purchase a few hundred thounsand shares (at least it will bring my average down hehehe)

I think the reason for the muted, if not slightly negtive reaction is perhaps a continued knowck on of the previous goals not being reached and the very low margin for gold price change before a loss is made. Until the biomass power plant is online and cash costs are reduced to less than $900 an ounce, all the while the exploration and development is underway if the price of gold drops by much more thsan $100 the company will be making a loss. Now, obviously the company is working towards reducing cash costs overall, and maybe the power plant will be online in a couple of years, but until then profitability will be low. The only two thing that will change the finances in the short term are 1. Gold price increasing significantly (short term its looking a little unsteady) or 2. cutting down on development (which would sacrifice long term targets of 100koz per annum. I held shares in VGM before the consolidation, and sold up after that at £2.15 a share. It was after that that the company cut its target to 60koz per annum for the medium term. When the power plant is a little furhter along and when development has progressed further I'll be back in as long term this company is really getting its act together. I think you'll be waiting longer than October though for a sustained recovery in price. Still, this price does represent value for the long term (though it may slip a little furhter still before recovering). GL to all holders :-)

Mate chillax a bit, there is nothing wrong with how this company is run. The company does not, and never has had, much cash. All their assets are in the percentages they own of other businesses, and the value will only be realised when their shareholdings are sold or those companies pay dividends to their shareholders. Consequently until disposals are made there is no/very litle inflow. Accoridngly to avoid burnng cash the directorsa are paid in shares. The other option is for the company to raise funds on the market after which they can afford to pay directors...which would have the same effect (dilution). In fact with the financing costs this would be worse. The directors have a right to be paid so you cannot begrudge them for that. With 39m shares in issue this is one of the lowest of any AIM share. Those who investy now have to appreciate that you are getting in at a very low price on a high risk/reward basis. Your alternative is to stay on the sidelines and await one of the companies in which IPS has a share to make a breakthrough or for IPS to sell it off. To do this means you risk not getting in quick enough and missing the rise when it happens. If you note the share price over the past year you will see that it has been comfortable between 3p and 5p excepting the P&D spike that recently occured (its what brought the company to my attention and my small holding is at a rather high average, but will average down later in the year at the right price). Therefore as an investor if you got in at any time except the spike you will probably not be much down and such loss, if any, will be easy to recoup. If any of the companies assets are sold you could find the share price will drastically increase due to the low number of shares in issue (imagine if Therakind was sold for example - their drug bucclam (bas spelling) is gaining a place accross more and more jurisdicitions and sales must therefore be increaseing making Therakind worth more and more every month). If you have a problem with the way this company is bing run then you should juts move away and find another share which suits your investment style.....I would look at the FTSE though as AIM is all about companies trying to maske it by contantly raising cash, doing deals etc so one day they can join the FTSE. GL

get back onto a real message board ya muppet!

Certainly shows further promise for the company and the chairman’s letter made good at justifying the directors fees being paid in shares. Even with the prospect of future dilution, this could be seen as a good company to take a punt on in the long term. Particularly with the Therakind Royalties that will be received (although we have never had the % disclosed to us it must be beneficial to the company and have the potential to generate a decent revenue, to which IPS will be entitled to 36% (albeit indirectly), Biocroí again is showing potential, especial if a large pharmaceuticals, who would be a primary Client, is involved. sure IPs is only holding 6% but 6% of something good is better than 10% of something based. IPSol Energy is of course the Company that has made the news noise in recent months, so again it will be interesting to see what develops here. Overall opinion of myself is this company has the potential to certainly go somewhere in the medium term (1 year +), and even if by that point there are 70-100m shares in issue the company could be then be capitalised at £5-7m+ representing a much higher sp if people buy in now. GL to all who stay in - my little holding will stay put :-)

why this company has a mcap of only £45.00 when it has just posted profits of £14m for the year. That at an avergae gold price of $1370ish, which will be consistently higher. They have raised funds to fund their most recent acquisition so if gold and production prices remain steady they will be posting up to £20m profit next year. why then do they trade at only 3X their current profit margin?

That news was never going to have a massive effect though. Grab yourslf a cup of tea and a sleepig bag, its going to be quite a wait still, though with huge potential at the end. What makes this share all the more attrctive is the fact that only 214m shares in issue, which is nothing compared to ATC & EDL in the coal sector. This of course means that the dilution that may occur when funds have to be raised after the DFS will be far less than would otherwise be the case. ATB :-)

One of the peeps you refer to as jumping in at 14p was me :-) got in on AIM admission on the gamble tha it would go up rather than down. Down was inevitable I guess with the way all shares are at present. Got out at 8.7p (i think that was it anyway) and am just patiently watching on the sidelines to get back in when its more appropriate i.e. when the DFS is ready. exciting times are ahead as first production draws near, but its going to be quite a wait - and the other question of course is funding after the DFS. ATB

Thanks for the reply and yes I get it now. It begs the question then of what is the milestone payment to be made to Therakind as per the 15th Sept RNS, as it must clearly be a different sum based on the your post and the link to Viropharma's announcement. It also stil bugs me greatly that we do not know what percentage of royalties go to Therakind for the sale of the drug. Jonc - your logic is sound and I agree with your point of view entirely. You have noticed though that it means that you get a lot of flak (as evidenced by the ECR board in particular). As long as you are prepared to take the negative comments I say keep it up, its good to be given a reality check on occassion. GL

Been reading your posts over the past few days and indeed you have been correct. I can also understand the view of others however in that the company could now been seen as undervalued as a result of Therekind's progress (regardless of the other projects they have). Either view could have prevailed. I myself bough a miniscule chunk of 10k shares at 6.5p on the premise that whher they rose or fell I would top up accordingly. My view was that i didnt want to miss the boat if the company became worth, say, £20m on the back of this, but didnt want to overexpose myself either. Certainly over the coming months as the product sells the value of IPSO could increase gradually (as i believe you suggested before as well) towards the £10m mark depending on the level of royalties, which has not been disclosed so far as I have found, and how much Therakind grows as a consequence. also of course it depends on other company projects Also of course is the Cambridge Meditech agreement with Lantor (UK) which may or may not bear fruit in the next 8 months or so there theres another aspect to watch. Jonc, where do you believe the support level is on this share and what entry point, if any, are you looking for. I myself am not a great judge of retraces so your comments would be appreciated. Still liking the unfriendly banter on the ECR board btw. ATB